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Abstract
Background: Allergic rhinitis is one of the most prevalent manifestation 
of allergy, affecting over 15% of the population worldwide. Recent published 
clinical studies have shown that specific probiotics can improveallergic rhinitis 
clinical symptoms.
Findings: In this study, thirty one adult volunteers suffering from allergic 
rhinitis were enrolled in a crossover study evaluating the efficacy of the 
consumption of a product containing either L. paracasei-fermented milk or 
the placebo. Transcriptomic analysis was performed on unstimulated PBMC 
after each treatment period and analysis was adjusted for the crossover 
design. No differences were observed between PBMCs from probiotic treated 
allergen challenged allergic patients and PBMCs from placebo treated allergen 
challenged allergic patients. 
Conclusion: This study shows that, in the blood compartment, PBMCs 
mRNA levels are too stable to mirror the changes of symptoms and alteration of 
cytokine expressions observed after a treatment with L. paracasei.
Trial Registration: NCT01150253. Registered 23 June 2010.
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with L. paracasei-fermented milk or with the placebo, separated by a 
wash-out period of 6 weeks (Figure 1). This clinical trial demonstrated 
a significant reduction in nasal congestion in subjects receiving 
fermented L. paracasei milk compared to placebo treated subjects. 
Additionally, lower IL-5 expression level in grass pollen restimulated 
peripheral blood mononuclear cells (PBMCs) was found associated 
with the consumption of L. paracasei-fermented milk and with the 
decreased in nasal congestion. Similar decrease was observed for 
allergen specific immunoglobulin G4 (IgG4) level in the L. paracasei-
fermented milk treated group. Nasal pruritus was improved in the 
group treated with L. paracasei-fermented milk but without reaching 
significant difference. 
In order to test whether PBMCs could be used as a predictor of 
symptom response, we sought to identify whether the L. paracasei-
fermented milk treatment was able to modify the gene expression 
profile of unstimulated PBMCs compared to the placebo, and to 
correlate these gene expression levels with the cell counts in nasal 
fluids, immunoglobulin levels and cytokine expressions in grass 
Abbreviations 
PBMC: Peripheral Blood Mononuclear Cell; RT-Q-PCR: 
Reverse Transcription-Quantitative-Polymerase Chain Reaction; 
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Introduction
Allergic rhinitis prevalence has dramatically increased over 
the last past decades reaching up to 15.7% of the populations [1]. 
Pharmacologic treatments for allergic rhinitis are available but with 
some side effects that affects the quality of life of the patients. Probiotics 
have been largely tested in the context of atopic dermatitis, allergic 
rhinitis and food allergy prevention or treatment [2-7] and have been 
shown to modulate the immune system dampening the Th2 response 
and potentiating T regulatory cell population and IL-10 production 
[8]. Ex vivo, Th2 skewed PBMCs stimulated with probiotics such as 
L. paracasei NCC2461 ST11 show an increase in TNF-α, IFN-ɣ and 
IL-10 productions and decrease in IL-5 production [9], or ex vivo 
in atopic patients [10,11]. Epigenetic mechanisms involving RNA 
stability have been described with L. paracasei NCC2461-stimulated 
PBMCs [12].Two previous clinical trials (CT) have shown that the 
probiotic L. paracasei NCC2461 can improve the nasal congestion or 
the nasal pruritus after a nasal provocation test [13,14].  Both trials 
strongly suggested that the consumption of L. Paracasei NCC2461 
may benefit grass pollen induced allergic reaction. In the second 
trial [14], designed as a randomized double-blind placebo controlled 
crossover study, 31 adult volunteers, aged between 18 and 35 years old, 
suffering from allergic rhinitis were enrolled. The crossover study was 
based on two-times 4-week periods of product consumption either 
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Figure 1: Schematic design of the crossover, placebo-controlled study. 
Double blind and cross over study for comparison of two interventions (with 
or without L. paracasei). SPT: Skin Prick Test; PBMC: Peripheral Blood 
Mononuclear Cells; NTP: Nasal Provocation Test.
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pollen re-stimulated PBMCs.
Materials and Methods
RNA extraction and transcriptomics analysis
RNA was prepared from PBMC (107 cells) using RN Easy midi 
kits (Qiagen, Venlo, Netherlands), incorporating a DNase1 digestion 
step, according to the manufacturer’s instructions. Total RNA yield 
was determined using a NanoDrop® ND-1000 spectrophotometer 
(Thermo Scientific, Waltham, Massachusetts, United States) and 
purity assessed by the ratios of absorbance at 260:280 and 260:230 nm. 
RNA integrity was assessed using Agilent RNA6000nano LabChips® 
(Agilent Technology 2100 Bioanalyzer Version A.01.20 SI211, Santa 
Clara, California, USA).  The RNA samples were aliquoted (10 µg) 
and stored at -80°C. RNA were prepared according to manufacturer’s 
instruction for the hybridization to Affymetrix human U133 Plus 
2 arrays (Santa Clara, California, USA). The raw data for all the 48 
arrays (.CEL files) were uploaded into GeneSpring 9.0.6 (Agilent 
Technologies, Santa Clara, California, USA) and analyzed. Statistical 
analyses (paired t-tests incorporating Benjamini and Hochberg 
multiple test correction) were then used to perform a number of 
specific group comparisons.
Real time PCR-PCT
Reverse transcription was performed using qScript reverse 
transcriptase (Invitrogen, Carlsbad, California, United States) and 
quantitative real-time polymerase chain reaction (RT-Q-PCR) was 
carried out using Platinum SYBR Green qPCR Supermix-UDG with 
ROX (Invitrogen) on an ABI Prism 7900HT Fast Real-Time PCR 
system (Applied Biosystems, Foster City, California, United States). 
The PCR was performed with 40 cycles of the following conditions: 
denaturation for 15s at 95°C, annealing for 15s at 60°C and extension 
for 30s at 72°C. The primer sets used to perform real-time PCR are 
listed in Table 1. The mRNA sequences were used in the Primers3 
software (http://simgene.com/Primer3) to select pairs of matching 
primers. Synthetic primers were obtained by Microsynth AG 
(Balgach, Switzerland). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as the house-keeping gene and the results were 
calculated using a standard curve for each gene. Results are then 
expressed as a ratio compared to the house keeping gene. 
Cytokines expression
Cytokines (IL-4, IL-5, IL-8, IL-10 and IFN-g) were measured 
Figure 2: Relative mRNA expression of candidate genes. Effect of L. paracasei NCC2461 and placebo treatment of inflammatory cytokine gene expression in 
PBMC. IL5, IL6, IL8, IL13, IFNG, TNFAIP6 and TNFRSRF17 mRNA expression levels were measured by RT-Q-PCR. Results are expressed as ratio relative to 
housekeeping gene GAPDH. 
Gene Forward primer (3'-5') Reverse primer (5'-3')
B2M TTCATCCATCCGACATTGAA CCTCCATGATGCTGCTTACA
IL5 GAGACCTTGGCACTGCTTTC CAGTACCCCCTTGCACAGTT
IL6 AGGAGACTTGCCTGGTGAAA CAGGGGTGGTTATTGCATCT
IL8 TAGCAAAATTGAGGCCAAGG AAACCAAGGCACAGTGGAAC
INFg TCCCATGGGTTGTGTGTTTA AAGCACCAGGCATGAAATCT
TNFAIP6 TCACATTTCAGCCACTGCTC AGACCGTGCTTCTCTGTGGT
TNFRSF17 GCAGTGCTCCCAAAATGAAT GTCCCAAACAGGTCCAGAGA
PTGS2 TGAGCATCTACGGTTTGCTG TGCTTGTCTGGAACAACTGC
GAPDH GAGTCAACGGATTTGGTCGT TTGATTTTGGAGGGATCTCG
Table 1:  Human primers pairs used for real-time PCR.
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on grass pollen re-stimulated PBMCs as previously described [14]. 
Detection limits of the multiplexed bead-based flow cytometry assay 
were 0.6, 0.2, 0.55, 1.19 and 0.87 pg/L, respectively. 
Statistical analysis
PCR cytokines expression levels and correlations were performed 
using R version 3.1.2 (https://cran.r-project.org/bin/windows/base/
old/3.1.2/) and graphs generated with GraphPad Prism 7 (GraphPad 
Software, Inc. La Jolla, California, USA).
Results
Transcriptomic analysis using Affymetrix human U133 Plus 2 
arrays was performed and adjusted for the crossover design (Figure 
1). Comparison of the ~47,000 transcripts expression profiles for 
samples collected immediately prior to both interventions identified 
no significant differences between the groups when a false discovery 
rate was applied (FDR<0.05) in the statistical analysis. Due to the 
challenge of detecting the often small changes in gene transcription 
resulting from nutritional interventions, such comparisons are often 
reported without corrections for multiple tests. However, even with 
the false discovery rate omitted from the analysis, the number of 
significant genes (p<0.05) was lower than the expected number of 
false positive tests for the number of comparisons performed before 
and after the intervention with placebo or L. paracasei. Similarly, 
no genes were identified as changing in expression as a result of 
the L. paracasei-fermented milk intervention compared to placebo 
when the false discovery rate was applied. However, in this case, 
when the false discovery rate was omitted, the number of genes for 
which the uncorrected p values was <0.05 was substantially higher 
(approximately 3-fold) than the expected number of false positive 
tests for the number of comparisons performed. 
Because some cytokine transcripts are not always detected using 
microarray techniques, we used a candidate approach. To address 
this issue, a subset of candidate genes was selected based on the 
transcriptomic results and the known Th2 cytokines responding to 
probiotics intervention (IL-8; IFNγ). No significant differences were 
observed between the placebo group and the L. paracasei-fermented 
milk treated group for the different molecular markers analyzed by 
RT-Q-PCR in PBMCs (Figure 2) thus confirming the null findings 
obtained by transcriptomics. Interestingly, a negative correlation 
(Spearman’s r=-0.63, p=0.03) between interleukin-8 (IL8) mRNA 
expression and IL-8 secretion in the supernatant of grass pollen 
re-stimulated PBMC was observed in the L. paracasei-fermented 
milk treated group, while no statistical association was found for 
the placebo treatment (Spearman’s r=0.58, p=0.05, Figure 3A). A 
significant positive correlation was also observed with IFNG mRNA 
level in PBMC and interferon-γ (IFN-γ expression level in grass 
pollen re-stimulated PBMC in the placebo group (Figure 3B). 
Correlations between interleukin-13 (IL13), interleukin-6 (IL6)
and tumor necrosis factor alpha induced protein 6 (TNFAIP6)
expression and neutrophil, leucocyte and eosinophil cell counts in 
nasal fluids, IgE in serum, and cytokine expressions in grass pollen 
restimulated PMBCs were all non-significant (data not shown). 
Discussion
Transcriptomics analyses have been widely used in human 
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Figure 3: Correlation between mRNA and protein expression level in PBMCs. Comparison of cytokine expression in restimulated PBMC with grass pollen and 
mRNA expression level by quantitative PCR in unstimulated PBMCs. Correlation ofIL-8 (a) and IFN-γ (b) for both the placebo and L. paracasei treated group are 
shown. 
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tissues including some studies with PBMCs [15,16]. Persson H, et al. 
have recently demonstrated differential expression levels in therapy 
sensitive asthma patients versus treatment refractory asthma patients 
using peripheral blood leucocytes transcriptomic [17]. However blood 
PBMC is a mix of different cells that seems to be very well controlled 
for its overall gene expression [18]. Interestingly, amore recent study 
has shown that even when cells were isolated, proteomics emphasized 
only mild differences between allergic and non-allergic individuals 
[19]. It is thus not surprising retrospectively, that no differences were 
observed between PBMCs from probiotic treated allergen challenged 
allergic patients and PBMCs from placebo treated allergen challenged 
allergic patients. The intervention with L. paracasei-fermented milk 
may have influenced gene expression profiles but the effect was subtle 
resulting in a difficulty to separate real effects on the level of individual 
genes from random effects due to biological noise. It is possible that 
only a small subset of cells did respond to the probiotic treatment 
but the response may be diluted in the whole PBMC leading to an 
undetectable signal when looking at transcriptomic analysis of non-
stimulated PBMCs. All together, these results suggest that the gene 
expression levels were highly stable in all individuals no matter the 
timing in the protocol or treatment at the time of the sampling. 
The negative correlation of IL8 mRNA and IL-8 secretion level in 
the supernatant of grass pollen re-stimulated PBMCs suggests that 
PMBC mRNA level for IL8 may inversely predict the responses in 
re-stimulated PBMCs in L. paracasei-fermented milk treated group. 
The discrepancy between the observed IL-8 results could be explained 
by the nature of the probiotics used. Depending on the physiological 
state of a given probiotic, specific mRNA may be specifically stabilized 
hence creating variations in effects after a probiotic treatment [12].
One should keep in mind that the results of the clinical trial have 
shown significant but mild decrease of clinical symptoms possibly 
explaining the lack of differences in our transcriptomic analysis. 
Another limitation of the study is the absence of results before the 
nasal provocation test (NPT) as the clinical trial was designed to 
assess clinical and molecular parameters (including gene expression 
in PBMCs) before and after probiotic treatment. As such the lack of 
PBMCs analysis before the NPT prevent analysis of the probiotic 
treatment efficacy on gene expression in PBMCs before challenge. 
Additionally the PMBCs were not stimulated ex vivo with the 
allergens, while this could have led to results better correlated to the 
cytokine expressions quantified after restimulation. Whalen K, et al. 
have shown that restimulated PBMC transcriptomic could separate 
healthy from allergic patients [20]. However the goal here was to 
assess baseline unstimulated gene expression changes that could be 
responsible for the differences observed ex vivo on cytokines secretion 
levels following ex vivo re-stimulation with the grass pollen extract.  
Taken altogether, these results suggest that in the context of this 
probiotic intervention, the blood compartment and more specifically 
PBMC mRNA level is too stable to reflect the subtle changes of 
symptoms and alteration of cytokine expression triggered by a 
treatment with L. paracasei. The effect of a probiotic treatment on 
the systemic compartment may be too tenuous to reflect the clinical 
symptoms alterations.
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